Peripheral Arterial Disease Clinical Trials in Miami, Florida

4 studies are recruiting for peripheral arterial disease in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. EVERO Drug-coated Balloon (DCB) Randomized Trial

    The primary objective of the study is to evaluate the long-term safety and effectiveness of the Advance Evero™ 18 Everolimus-coated Percutaneous Transluminal Angioplasty Balloon Catheter (hereafter referred to as the Evero drug-coated balloon [DCB]) in the treatment of the femoropopliteal artery le…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Baptist Cardiac and Vascular Institute, Miami, Florida
    Locations
    10 in total
    Run by
    Cook Research Incorporated

    See if you can join NCT07144150 on ClinicalTrials.gov

  2. The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

    The objective of this study is to establish reasonable assurance of safety and effectiveness of the Golazo® Peripheral Atherectomy System when used as indicated in 159 subjects with symptomatic infrainguinal peripheral arterial disease (PAD) in up to 20 investigational sites in the U.S.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Amavita Research Services, Miami, Florida
    Locations
    20 in total
    Run by
    Nipro Vascular Innovations Americas, Inc

    See if you can join NCT06321575 on ClinicalTrials.gov

  3. The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate）and Plavix® in Healthy Participants

    CG-0255 is a novel investigational prodrug of the active metabolite of Plavix®， but with different active metabolite conversion routes. This is a randomized, open-label and Plavix®-controlled study to compare the PK and PD of CG-0255 Besylate and Plavix® in healthy participants.

    Stage
    Phase 1
    Ages
    18 to 55
    Site
    Syneos Health, Miami, Florida
    Run by
    Shanghai CureGene Pharmaceutical Co., Ltd.

    See if you can join NCT07619885 on ClinicalTrials.gov

  4. SELUTION4BTK Trial

    This study aims to demonstrate superior efficacy and equivalent safety of the SELUTION SLR™ DEB 014 compared to plain (uncoated) balloon angioplasty in the treatment of peripheral arterial disease (PAD) in the BTK arteries in CLTI patients.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Palm Vascular Centers, Miami, Florida
    Locations
    48 in total
    Run by
    M.A. Med Alliance S.A.

    See if you can join NCT05055297 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.